SCHEMBL6311104

SCHEMBL6311104

COC(=O)c1ccc(Cc2c(C)c(C#N)c3nc4ccccn4c3c2Cl)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ENPP2 Q13822 1/20 0.41
ALDH1A1 P00352 3/20 0.40
RXFP1 Q9HBX9 1/20 0.40
DRD2 P14416 2/20 0.39
TBXA2R P21731 2/20 0.39
AR P10275 1/20 0.39
KDM4E B2RXH2 2/20 0.38
DAPK3 O43293 1/20 0.38
JAK2 O60674 1/20 0.38
PRKD3 O94806 1/20 0.38
MAP4K4 O95819 1/20 0.38
ABL1 P00519 1/20 0.38
CSF1R P07333 1/20 0.38
RET P07949 1/20 0.38
MET P08581 1/20 0.38
PDGFRA P16234 1/20 0.38
PRKACA P17612 1/20 0.38
LTK P29376 1/20 0.38
GRK5 P34947 1/20 0.38
KDR P35968 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6317979 0.87 ADORA3 (0.43) ENPP2ALDH1A1KDM4ESMN1; SMN2MAPK1
SCHEMBL6311004 0.86 ENPP2 (0.43) ENPP2ALDH1A1KDM4ESMN1; SMN2MAPK1
SCHEMBL6312701 0.85 ENPP2 (0.43) ENPP2ALDH1A1ARKDM4ESMN1; SMN2
SCHEMBL6319758 0.83 ENPP2 (0.41) ENPP2ALDH1A1KDM4ESMN1; SMN2LMNA
SCHEMBL6310705 0.82 ENPP2 (0.39) ENPP2ALDH1A1KDM4ESMN1; SMN2MAPK1
SCHEMBL6318124 0.79 ALDH1A1 (0.43) ALDH1A1RXFP1KDM4ESMN1; SMN2MAPK1
SCHEMBL6310328 0.79 NPSR1 (0.44) ENPP2ALDH1A1RXFP1KDM4ESMN1; SMN2
SCHEMBL6318776 0.79 ALDH1A1 (0.41) ENPP2ALDH1A1RXFP1SMN1; SMN2LMNA
SCHEMBL6311410 0.79 PIK3CD (0.38) ENPP2ALDH1A1KDM4ESMN1; SMN2MAPK1
SCHEMBL6311689 0.79 ALDH1A1 (0.40) ALDH1A1RXFP1KDM4ESMN1; SMN2MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113397-A1 Imidazo[1,2-a]pyridine derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2005-05-26 US disclosed
EP-1479681-A1 IMIDAZO(1,2-a)PYRIDINE DERIVATIVE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2004-11-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113397-A1 Imidazo[1,2-a]pyridine derivative MANBA, MAN2B1, ERG28 ENPP2 4010/4885ALDH1A1 2550/4885RXFP1 1521/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.